Cardiac

Allograft Bio-Implants for Cardiac Procedures

Suitable for a wide variety of complex congenital heart defects, as well as for adults with extensive valvular disease. The CardioGRAFT® line of tissue grafts offers heart valves, repair grafts, conduits and decellularized tissue grafts with Matracell® decellularization technology.

To download or print our Corporate Brochure click here.

To download or print our Matracell® Brochure click here

Visit our booth at AATS to learn more about why The Choice is Natural when treating Infective Endocarditis.

Description

CardioGRAFT® Aortic Heart Valve

Benefits
  • No anticoagulation therapy required
  • Exceptionally good hemodynamic performance
  • No immunosuppressive therapy needed
  • Non-thrombogenic
  • Non-hemolytic
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Left side/aortic reconstruction
  • Aortic stenosis/atresia
  • Hypoplastic left heart
  • Repair of RVOTs (Right Ventricular Outflow Tract)
CryopreservedDescriptionSize
HVA-S

Aortic Heart Valve

D ≤ 16 mm
HVA-M

Aortic Heart Valve

D = 17 - 21 mm
HVA-L

Aortic Heart Valve

D ≥ 22 mm
Description

CardioGRAFT® Pulmonary Heart Valve

Benefits
  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Right side/pulmonary reconstructions
  • Hypoplastic left heart (modified Fontan)
  • Ross procedure
  • Truncus arteriosus
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Pulmonary root stenosis
CryopreservedDescriptionSize
HVP-S

Pulmonary Heart Valve

D ≤ 16 mm
HVP-M

Pulmonary Heart Valve

D = 17 - 21 mm
HVP-L

Pulmonary Heart Valve

D ≥ 22 mm
Description

CardioGRAFT® Ascending Aorta non-valved

Benefits
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
  • No anticoagulation therapy required
Clinical Application
  • Conduit repair
CryopreservedDescriptionSize
AAS

Ascending Aorta (non-valved)

D ≤ 16 mm
AAM

Ascending Aorta (non-valved)

D = 17 - 21 mm
AAL

Ascending Aorta (non-valved)

D ≥ 22 mm
Description

CardioGRAFT® Pulmonary Artery (non valved)

Benefits
  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Right side/pulmonary reconstructions
  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus
  • Pulmonary root stenosis
CryopreservedDescriptionSize
PAS

Pulmonary Artery (non-valved)

D ≤ 16 mm
PAM

Pulmonary Artery (non-valved)

D = 17 - 21 mm
PAL

Pulmonary Artery (non-valved)

D ≥ 22 mm
Description

CardioGRAFT® Thoracic Aorta

Benefits
  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Infected descending aorta  
  • Conduit repair
  • Extra-cardiac shunt
CryopreservedDescriptionSize
TAS

Thoracic Aorta

D ≤ 16 mm
TAM

Thoracic Aorta

D = 17 - 21 mm
TAL

Thoracic Aorta

D ≥ 22 mm
Description

CardioGRAFT® Hemi-Pulmonary Artery

Benefits
  • No Anticoagulation therapy required
  • Non-thrombogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Tetralogy of Fallot
  • Pulmonary atresia
  • Single ventricle/double outlet (Fontan)
  • Truncus arteriosus
  • Transposition of great vessels 
  • Hypoplastic left heart (modified Fontan)
  • Aortic stenosis/atresia
     
DescriptionSize
LHPALeft Hemi-Pulmonary ArteryVaries
RHPARight Hemi-Pulmonary ArteryVaries
Description

CardioGRAFT® Mono Cusp Patch

Benefits
  • Single valved section of main pulmonary trunk
  • Original annulus diameter
  • Length and width measured in centimeters
  • No minimum or maximum width
Clinical Application
  • Tetralogy of Fallot
  • RVOT/root enlargement procedures
CryopreservedDescriptionSize
MCPL

Mono Cusp Patch

≥ 22 mm
Description

CardioGRAFT® Pulmonary Patch section produced from the main pulmonary artery

Benefits
  • No anticoagulation therapy required
  • Non-thromogenic
  • Non-hemolytic
  • No immunosuppressive therapy required
  • Human tissue - most closely resembles native tissue
  • High resistance to infection
Clinical Application
  • Right side/pulmonary reconstructions
  • Tetralogy of Fallot
  • Single ventricle/double outlet (Fontan)
  • Truncus arterious; ASD/VSD repair
CryopreservedDescriptionSize
PPGK

Thick (Trunk)

W = 2.5 - 5 cm; L = 3 - 8 cm
PPGN

Thin (Branch)

W = 2.5 - 5 cm; L = 3 - 8 cm
Description

CardioGRAFT® Decellularized Pulmonary Patch with Matracell®

Clinical Application
  • RVOT Repair
FrozenDescriptionSize
DPPGK

Thick (Trunk)

W = 2.5 - 5 cm; L = 3 - 8 cm
DPPGN

Thin (Branch)

W = 2.5 - 5 cm; L = 3 - 8 cm
Description

CardioGRAFT® Decellularized Hemi-Pulmonary Artery with Matracell®

Benefits
  • Matracell safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant
Clinical Application
  • RVOT Repair
Alternative Products

Decellularized Hemi-Pulmonary Artery with Matracell

FrozenDescriptionSize
DLHPA

Left 

Multiple options, varies by donor
DRHPA

Right

Multiple options, varies by donor